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PRELIMINARY AND SHORT REPORTS
THERAPEUTIC ASSAYS OF THE SKIN AND CANCER UNIT OF THE NEW YORK
UNIVERSITY HOSPITAL*
ASSAY VI.—ADENOSINE-5-MONOPHOSPHATE (MY-B-DEN) roi' THE RELIEF OF PRurrus
H. H. SAWICKY, M.D., NORMAN B. KANOF, M.D., DANIEL E. HACEBARTE, M.D., AND
IRVING E. MARES, M.D.
Muscle adenylic acid (adenosine-5-monophosphate) was used by Rottino in an attempt to
counteract the loss of physical energy found in Hodgkin's disease. He noted cessation of
pruritus in patients receiving this medication and extended its use to other pruritic condi-
tions (1,2, 5). Kennedy (3) has also reported favorably on the use of muscle adenylic acid
for the relief of pruritus. In the hands of Rostenberg and his co-workers, it failed to relieve
pruritus in atopic dermatitis (4).
To more fully evaluate the usefulness of this drug to the dermatologist, we employed it in
a group of patients hospitalized at the University Hospital, N. Y. U.—Bellevue Medical
Center, and also on a large group of patients treated on an ambulatory basis at the Skin and
cancer Unit of the N. Y. 1J.—Bellevue Medical Center.
METHOD
Thirteen (13) hospitalized patients were treated by intramuscular injections of MY-B-
DENt. They received 20 milligrams (ice) hourly for five consecutive hours each day for
from 3 to 10 days. No placebo injection was used as a control.
The 02 patients treated in the clinic on an out-patient basis received a linguet which was
dissolved under the tongue hourly for 5 consecutive hours toward the end of the day. Some
patients received linguets which contained 20 milligrams of MYBDEN*, and some re-
ceived linguets containing only lactose as a placebo control. The participating physicians
did not know which linguets were placebos and which were not, and the patients received
first one, then the other, then the first again, so that a comparison of the drug and the con-
trol in the same patient was obtained.
Comparison and evaluation of results is based, in all cases, on the subjective response of
the patients to careful questioning by a single interrogator.
MATERIAL AND RESULTS
The hospitalized cases treated with MY-B-DEN were classified as follows:
Dermatitis venenata, severe 6
Distinctive exudative discoid and lichenoid chronic dermatosis (Sulzberger and
Garbe) 4
Pemphigus vulgaris 1
Dermatitis herpetiformis 1
Amyloidosis cutis 1
The drug did not influence the pruritus either favorably or unfavorably in any of these
cases. No untoward side effects were observed during the administration of the drug.
The type of ambulatory patient treated with MY-B-DEN, and the results of the treat-
ment are shown in Table I. Of the 92 patients, 20 (22%) reported diminution of pruritus.
* From the Department of Dermatology and Syphilology of the New York University
Post-Graduate Medical School (Dr. Marion B. Sulzberger, Chairman), and the Skin and
Cancer Unit of the University Hospital.
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However, 8 of these patients (9% of the total, and 40% of the group that was aided by MY.
B-DEN) were also helped by the placebo linguet.
TABLE I
Patients treated with oral preparation
ISEASES TOTAL NO.OF CASES
DEFINITE
RELIEF OF
PRUBITDS
WITH ADE-
NOSINE-S-
MONO.
DEFINITE
BELIEF
WITH
PLACEBO
RELIEF
WITH
EITHER
PLACEBO OR
ADENOSINE-
S-MONO.
NO BILrEP
WITH
B
ADENOSINE-
-MONO.
Stasisdermatitisand/orStasisUlcer.... 18 6 1 1 10
Neurodermatitis 15 4 0 2 9
Pruritus Ani, Vulvi and/or Scroti 10 1 0 0 9
Dermatitis Venenata 10 2 0 2 6
Senile Pruritus 5 1 0 0 4
Lichen Planus 5 0 0 0 5
Dermatitis herpetiformis 4 0 0 0 4
Seborrheic dermatitis 6 1 0 1 4
Bath Pruritus 2 1 0 0 1
Distinctive exudative discoid & lichen.
oid chronic dermatosis 2 0 0 1 1
Pruritus hiemalis 2 0 0 0 2
Psoriasis 2 0 0 0 2
Tinea cruris 2 0 0 0 2
Tinea versicolor 2 1 0 0 1
Chronic urticaria 2 0 0 0 2
Neurotic excoriations 2 1 0 1 0
Pityriasis rosea 3 2 0 0 1
SUMMART
Taking into account the psychological effect of any 'new' remedy (particularly one given
in such an unusual sequence, i.e., every hour for five hours each day) and the number of
patients who benefited as much from the placebo as from the remedy under consideration,
we conclude that adenosine-5-monophosphate is not an effective antipruritic agent.
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